$ARDX

Ardelyx options trading surges as stock falls 18%

According to exchange data compiled by Bloomberg and reported by Investing.com, Ardelyx Inc. options activity rose Friday morning to 11,147 contracts, with puts dominating (10,676). The October 16, 2026 $4 put led with 10,004 contracts. Ardelyx shares fell 18.4% to $3.98, and 3-month volatility rose to 74.93%.

Original reporting
Published Aug 7, 2026, 2:18 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 2:37 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefMarket movers
Primary signal
$ARDX
Bearish
medium confidence
Mentioned
$ARDX
Relevance
6/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$ARDXBearishMed
01

Why it matters

For traders, the actionable signal is the combination of a steep equity drop and unusually high, put-heavy options volume, which can amplify implied volatility and influence short-dated pricing.

02

Market read

ADX options flow (puts dominating) during a sharp selloff points to heightened near-term downside risk perception and volatility.

03

What to watch

The article does not explain the fundamental driver of the 18.4% drop, so options activity may be reacting to an external catalyst not captured here.

Relevance 6/10Novelty 5/10Timing: Friday morning options surge during the 18.4% stock drop

Background

The piece reports exchange-tracked options activity for Ardelyx alongside a large same-day share decline.

Company-level read

Ticker impact

$ARDXBearishMedium confidence
Context

Ardelyx shares fell 18.4% to $3.98 while options volume spiked to 11,147 contracts, with puts dominating at 10,676.

Expected impact

Near-term volatility likely remains elevated as traders react to the large move and heavy put demand.

Evidence & confidence

The text provides same-day price decline and detailed options flow (calls vs puts, specific put strike and open interest), but no new fundamental catalyst beyond the move itself.

Market effects

No sector-wide read-through is provided beyond a single small-cap biotech-style name showing heightened hedging demand.

None stated.

None stated.

Counterpoint

Put volume could reflect hedging by existing holders rather than fresh bearish conviction, so downside follow-through may be less certain.

Key entities

  • Ardelyx Inc.

    US-listed company whose shares fell 18.4% and whose options volume surged with heavy put participation.

Related articles

$ARDXHighAI 9/10

Why is Ardelyx stock plunging today?

Ardelyx (ARDX) shares fell about 16% pre-open after the company reported Q2 2026 results that missed Wall Street on revenue and EPS and cut full-year guidance. Q2 total product revenue was $118.1M, net loss $16.7M (-$0.07/share). Ardelyx lowered 2026 IBSRELA revenue guidance to $350–$370M and withdrew a prior XPHOZAH long-term target.

$ARDXMed

ARDELYX, INC. (ARDX): Results of Operations and Financial Condition

ARDELYX, INC. (ARDX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ardx-20260630xexhibit991.htm EX-99.1 Document Exhibit 99.1 Ardelyx Reports Second Quarter 2026 Financial Results and Provides Business Update Q2 2026 total product revenue of $118.1 million, reflecting 31% growth year-over-year IBSRELA Q2 2026 revenue growth of 33% year

$BTGMedAI 8/10

B2Gold Shares Surge 23% After Mali Permit Boosts Fekola Growth Outlook

B2Gold’s shares (BTG) rose 23.1% to $5.03 on Aug. 7 after Mali issued the Menankoto permit for the Fekola mine. B2Gold said Fekola Regional targets over 150,000 ounces annually from 2028 and tightened 2026 production guidance to 820,000–920,000 ounces. Adjusted EPS was $0.03 vs $0.07 consensus; cash was $287m.

Med

Centerra Gold (TSX:CG) Is Up 22.9% After Raising 2026 Gold Guidance And Boosting Shareholder Returns – Has The Bull Case Changed?

Simply Wall St reports Centerra Gold’s Q2 2026 results: US$442.71m sales and US$72.12m net income, plus a confirmed quarterly C$0.07 dividend. The company raised 2026 gold production guidance to 260,000 to 290,000 ounces and confirmed 2026 copper guidance of 50 to 60m pounds, alongside buybacks. The article cites 2028 targets of $1.6b revenue and $106.3m earnings.

$GDDYMed

Wall Street Is Losing Confidence in GoDaddy’s (GDDY) AI Strategy. Should Investors?

GoDaddy (NYSE:GDDY) reported Q results of $1.83 EPS and about $1.30B revenue, both above consensus, but the stock fell about 12%. Bookings rose 6% to $1.4B, while Applications and Commerce bookings growth slowed to 7% from 9%. Analysts cited concerns over agentic AI transition noise; management is accelerating Airo and cutting legacy investment. Q3 revenue guidance is $1.32B-$1.34B.